Case Report: Control of Epilepsia Partialis Continua with Medical Management
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INTRODUCTION

Although the jerking movements associated with EPC are slower than most other
forms of status epilepticus 4,5, the disorder can be debilitating to affected patients,
especially since they often require long courses of multiple AEDs to control. Given
the rarity of this disorder (estimated less than one per million 2,4), any case report
documenting effective control of EPC is noteworthy.
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DISCUSSION/CONCLUSION

CASE PRESENTATION

Epilepsia Partialis Continua (EPC) is a rare and notoriously treatment-refractory
form of focal motor status epilepticus, classically associated with focal involuntary
movements and cognitive impairment that can persist for weeks, months, or even
years despite appropriate therapy with antiepileptic drugs (AEDs) 1-4. It is almost
universally caused by an underlying cortical lesion such as an infarct, neoplasm,
congenital malformation, encephalitis, or tuberculoma1-4. Metabolic causes such as
hyperglycemia have also been reported 1,2,4.
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• Patient: 74-year-old right-handed Caucasian male.
• Presentation: altered mentation, mixed transcortical aphasia, right-sided hand and face twitching the day
after a mechanical fall at home.
• Imaging: CT head left temporal intraparenchymal hematoma and small left frontotemporal subdural
hematoma. CTA head/neck no underlying aneurysm or vascular malformation.
• EEG: epilepsia partialis continua, originating from left temporal leads. Routine 20-minute EEGs
were performed daily after the initial EEG report.
• Medical history: hypertension, hyperlipidemia, depression, benign prostatic hypertrophy. Per family his
baseline memory was declining but he could manage finances, drive alone, and converse normally.
• Medications: no antiplatelets, anticoagulants, or other home medications.
• Physical exam: repetitive, involuntary twitching of right hand, right eyelid, and right side of the mouth.
Follows simple commands with hints and pantomiming, but often fixates on a single command. Speech
consists of repeating a single word or syllable, although he attempts to respond to conversation.
• Treatment: started IV Levetiracetam and IV Lacosamide, titrated to maximum tolerated doses. Next
started IV Fosphenytoin with a loading dose, and serum levels were monitored. Pulsed doses of IV methylprednisolone and IV magnesium sulfate were also given. Due to a shortage of IV formulation, a PEG tube
was placed for PO Valproate, and serum levels were monitored.
• Results: EEGs showed diminishing EPC discharges coinciding with clinical improvement, and nine days
after presentation an EEG found only moderate bihemispheric slowing. Daily EEGs failed to show any
recurrence of EPC.
• Modification: Titration off of four AEDs began two days after resolution of EPC. First Foshenytoin was
weaned, then Keppra, then Lacosamide. Lamotrigine was slowly started with plans to wean Valproic acid
after discharge.
• Follow up: CT head three weeks after presentation negative for residual blood. Contrast MRI brain
afterwards negative for underlying lesion.
• Resolution: Involuntary movements ceased with resolution of EPC on EEG. Other clinical improvement
followed resolution of bleeding on imaging. Three to four weeks after presentation patient appeared alert
and was able to follow commands reliably and converse appropriately, although his memory was not at
baseline at time of his discharge six weeks after presentation.

DISCLOSURES

After clinical and electrophysiologic control of EPC, the decision to wean AEDs was made to
reduce sedation and limit adverse effects. Fosphenytoin was initially weaned due to its longterm side effect profile. Levetiracetam was then weaned due to new-onset irritable mood and
combativeness. Lacosamide was weaned as paroxysmal atrial fibrillation was seen on EKG.
Finally, the decision was made to wean off Valproate as serum levels were labile requiring
frequent dose adjustments. Lamotrigine was chosen for long-term therapy due to additional
benefits of mood stabilization; however, due to the requirement for slow titration, Valproate
was kept until Lamotrigine could be titrated to a therapeutic dose.
Epilepsia Partialis Continua typically has a poor prognosis due to difficulty controlling it with
AEDs 1,5. However, with aggressive treatment and EEG monitoring this patient had a good clinical
and electrophysiologic outcome, even with subsequent curtailing of therapy. It's possible that
EPC has a better prognosis if the underlying cause is acute rather than chronic 5, however
further study is required to elaborate on this.
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The decision of which AEDs to use was based on clinical judgement in combination with
evidence-based guidelines. A combination of medications with different mechanisms of action is
found to be effective6,10. Primary mechanisms include that of a voltage-gated sodium channel
modulator (Lacosamide), SV2A antagonist (Levetiracetam), voltage-gated sodium channel
antagonist (Fosphenytoin), and multiple mechanisms (Valproic acid) 10. AEDs chosen have been
shown effective both in broad spectrum and focal-specific epilepsies 7. Benzodiazepines have not
been shown to be effective long-term treatment for EPC2,4. Pulsed doses of steroids and
magnesium have also been shown to be useful in treatment-resistant status epilepticus,
although the mechanism of action for this is uncertain 8,9. Given the patient's
cognitive impairment, preference was given to AEDs available in IV formulation.
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